1.350USD+0.75%Mkt Cap: 458.70M USDP/E: —Last update: 2026-05-26
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product inclu…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap458.70M USD
Enterprise Value458.45M USD
Revenue (TTM)4.46M USD
Gross Profit-35.63M USD
Net Income (TTM)-67.85M USD
Revenue/Share0.0140 USD
Last Price1.350 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees116
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.93
PEG—
EV/EBITDA-7.18
EV/Revenue102.68
P/S102.35
P/B-34.62
EPS (TTM)-0.24
EPS (Forward)-0.23
52W Range
0.800029% of range2.725
52W High2.725 USD
52W Low0.8000 USD
Profitability
Gross Margin0.00%
Oper. Margin-1163.67%
EBITDA Margin0.00%
Profit Margin-1537.41%
ROE557.67%
ROA-155.91%
Growth
Revenue Growth3.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-56.96M USD
CapEx (TTM)185.00K USD
FCF Margin-753.99%
FCF Yield-7.34%
Net Debt1.44M USD
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity-2.72
Current Ratio1.86
Quick Ratio1.54
Book Value/Sh-0.0390 USD
Cash/Share0.0940 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateSep 30, 2019
Splits
Last Split1:60
Split DateSep 30, 2019
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)11.57 USD
Target Range7.000 USD – 22.00 USD
# Analysts7
Ownership
Shares Out.338.52M
Float316.86M
Insiders1.68%
Institutions34.01%
Short Interest
Short Ratio11.8d
Short % Float20.69%
Short % Out.20.58%
Shares Short69.67M
Short (prev mo.)64.75M
Technical
SMA 501.783 (-24.3%)
SMA 2001.506 (-10.3%)
Beta2.31
S&P 52W Chg28.31%
Avg Vol (30d)7.21M
Avg Vol (10d)6.02M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—